Ganciclovir Gel 0.3%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ganciclovir Gel 0.3%, covering 2012-05-17 to 2012-05-17. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus [Phase 3]